GE Healthcare to expand Cork facility with €132m investment

Expansion will enable 25m more patient doses per year of contrast media by the end of 2027

Kevin O’Neill, President & CEO, GE HealthCare’s Pharmaceutical Diagnostics, An Taoiseach Micheál Martin, Lorraine Marah, HR Director, GE HealthCare and Eugene Barrett, Managing Director, GE HealthCare Ireland at the turning of the sod at GE HealthCare in Carrigtohill, where construction works on a new €132 million contrast media manufacturing facility will shortly commence. The new 3000m2 facility will enable production of an additional 25 million patient doses per year of contrast media by the end of 2027, helping address growing global demand.

Medtech giant GE Healthcare said it will significantly expand its manufacturing site in Cork, announcing a €132m investment in a new state-of-the-art facility.

Located in Carrigtwohill, the extension will enable 25m more patient doses per year of contrast media by the end of 2027, helping address growing global demand.